BACKGROUND: The anterior nares are the most sensitive single site for detecting methicillin-resistant Staphylococcus aureus (MRSA) colonization. Colonization patterns of USA300 MRSA colonization are unknown. OBJECTIVES: To assess whether residents of extended care facilities who are colonized with USA300 MRSA have different nares or skin colonization findings, compared with residents who are colonized with non-USA300 MRSA strains. METHODS: The study population included residents of 5 extended care units in 3 separate facilities who had a recent history of MRSA colonization. Specimens were obtained weekly for surveillance cultures from the anterior nares, perineum, axilla, and skin breakdown (if present) for 3 weeks. MRSA isolates were categorized as USA300 MRSA or non-USA300 MRSA. RESULTS: Of the 193 residents who tested positive for MRSA, 165 were colonized in the anterior nares, and 119 were colonized on their skin. Eighty-four percent of USA300 MRSA-colonized residents had anterior nares colonization, compared with 86% of residents colonized with non-USA300 MRSA (P= .80). Sixty-six percent of USA300 MRSA-colonized residents were colonized on the skin, compared with 59% of residents colonized with non-USA300 MRSA (P= .30). CONCLUSIONS: Colonization patterns of USA300 MRSA and non-USA300 MRSA are similar in residents of extended care facilities. Anterior nares cultures will detect most--but not all--people who are colonized with MRSA, regardless of whether it is USA300 or non-USA300 MRSA.
BACKGROUND: The anterior nares are the most sensitive single site for detecting methicillin-resistant Staphylococcus aureus (MRSA) colonization. Colonization patterns of USA300 MRSA colonization are unknown. OBJECTIVES: To assess whether residents of extended care facilities who are colonized with USA300 MRSA have different nares or skin colonization findings, compared with residents who are colonized with non-USA300 MRSA strains. METHODS: The study population included residents of 5 extended care units in 3 separate facilities who had a recent history of MRSA colonization. Specimens were obtained weekly for surveillance cultures from the anterior nares, perineum, axilla, and skin breakdown (if present) for 3 weeks. MRSA isolates were categorized as USA300 MRSA or non-USA300 MRSA. RESULTS: Of the 193 residents who tested positive for MRSA, 165 were colonized in the anterior nares, and 119 were colonized on their skin. Eighty-four percent of USA300 MRSA-colonized residents had anterior nares colonization, compared with 86% of residents colonized with non-USA300 MRSA (P= .80). Sixty-six percent of USA300 MRSA-colonized residents were colonized on the skin, compared with 59% of residents colonized with non-USA300 MRSA (P= .30). CONCLUSIONS: Colonization patterns of USA300 MRSA and non-USA300 MRSA are similar in residents of extended care facilities. Anterior nares cultures will detect most--but not all--people who are colonized with MRSA, regardless of whether it is USA300 or non-USA300 MRSA.
Authors: Carlene A Muto; John A Jernigan; Belinda E Ostrowsky; Hervé M Richet; William R Jarvis; John M Boyce; Barry M Farr Journal: Infect Control Hosp Epidemiol Date: 2003-05 Impact factor: 3.254
Authors: Heather A Carleton; Binh An Diep; Edwin D Charlebois; George F Sensabaugh; Françoise Perdreau-Remington Journal: J Infect Dis Date: 2004-10-18 Impact factor: 5.226
Authors: Timothy S Naimi; Kathleen H LeDell; Kathryn Como-Sabetti; Stephanie M Borchardt; David J Boxrud; Jerome Etienne; Susan K Johnson; Francois Vandenesch; Scott Fridkin; Carol O'Boyle; Richard N Danila; Ruth Lynfield Journal: JAMA Date: 2003-12-10 Impact factor: 56.272
Authors: Linda K McDougal; Christine D Steward; George E Killgore; Jasmine M Chaitram; Sigrid K McAllister; Fred C Tenover Journal: J Clin Microbiol Date: 2003-11 Impact factor: 5.948
Authors: Lisa Saiman; Mary O'Keefe; Philip L Graham; Fann Wu; Battouli Saïd-Salim; Barry Kreiswirth; Anita LaSala; Patrick M Schlievert; Phyllis Della-Latta Journal: Clin Infect Dis Date: 2003-10-17 Impact factor: 9.079
Authors: Daniel J Livorsi; David J Livorsi; Sana Arif; Patricia Garry; Madan G Kundu; Sarah W Satola; Thomas H Davis; Byron Batteiger; Amy B Kressel Journal: Infect Control Hosp Epidemiol Date: 2015-01 Impact factor: 3.254
Authors: Simone M Shurland; O Colin Stine; Richard A Venezia; Jennifer K Johnson; Min Zhan; Jon P Furuno; Ram R Miller; Colleen Pelser; Mary-Claire Roghmann Journal: Infect Control Hosp Epidemiol Date: 2010-08 Impact factor: 3.254
Authors: Jon P Furuno; Simone M Shurland; Min Zhan; J Kristie Johnson; Richard A Venezia; Anthony D Harris; Mary-Claire Roghmann Journal: Infect Control Hosp Epidemiol Date: 2011-03 Impact factor: 3.254
Authors: Courtney R Murphy; Lyndsey O Hudson; Brian G Spratt; Victor Quan; Diane Kim; Ellena Peterson; Grace Tan; Kaye Evans; Hildy Meyers; Michele Cheung; Bruce Y Lee; Dana B Mukamel; Mark C Enright; Matthew Whealon; Susan S Huang Journal: Infect Control Hosp Epidemiol Date: 2013-01-23 Impact factor: 3.254
Authors: Christopher J Crnich; Megan Duster; Timothy Hess; David R Zimmerman; Paul Drinka Journal: Infect Control Hosp Epidemiol Date: 2012-09-21 Impact factor: 3.254
Authors: Susan S Huang; Rupak Datta; Sheryl Rifas-Shiman; Ken Kleinman; Hilary Placzek; Julie D Lankiewicz; Richard Platt Journal: Crit Care Date: 2011-09-14 Impact factor: 9.097